Skip to content

Drug interactions

Aprepitant + Clopidogrel

Severity: Minor

Aprepitant and Clopidogrel: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Clopidogrel is a prodrug partly activated by CYP3A4, so inhibiting this enzyme could reduce formation of the active metabolite. The clinical effect on platelet inhibition with aprepitant is uncertain and likely small, because CYP2C19 is the main activating enzyme.

What this interaction means in plain words

Aprepitant and Clopidogrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Aprepitant belongs to Gastrointestinal Tract; Clopidogrel belongs to Cardiovascular.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4, a contributing pathway for clopidogrel bioactivation.

What to do

No dose adjustment is needed. In high-risk patients such as those with recent stent placement, be aware of possible reduced antiplatelet effect during aprepitant therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Clopidogrel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Clopidogrel?

MediHelp rates the interaction as minor. Aprepitant and Clopidogrel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Clopidogrel is a prodrug partly activated by CYP3A4, so inhibiting this enzyme could reduce formation of the active metabolite. The clinical effect on platelet inhibition with aprepitant is uncertain and likely small, because CYP2C19 is the main activating enzyme.

How serious is the interaction between Aprepitant and Clopidogrel?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. In high-risk patients such as those with recent stent placement, be aware of possible reduced antiplatelet effect during aprepitant therapy.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in